We are live on ! Find out more

3 hedge funds and large institutions have $707K invested in Daxor in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $596K → $707K (+$111K)

0.06% more ownership

Funds ownership: 1.18% → 1.24% (+0.06%)

50% less funds holding

Funds holding: 6 → 3 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
3
Holders Change
-3
Holders Change %
-50%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DXR Hedge Fund Activity: Q2 2020 in Review

3 of the 4,889 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q2 2020, worth a combined $707K — up 19% from $596K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of DXR and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, opening a new position worth an estimated $319K. The largest seller was Diametric Capital, exiting entirely with an estimated $169K sold.

  • 3 institutional investors held Daxor (DXR) as of Q2 2020, down from 6 in Q1 2020.
  • Funds reported $707K of Daxor stock for Q2 2020, up 19% quarter-over-quarter.
  • 1 fund opened new Daxor positions in Q2 2020 and 4 closed out, a net change of -3 holders.
  • The largest Daxor buyer in Q2 2020 was Vanguard Group, an estimated $319K added.
  • The largest Daxor seller in Q2 2020 was Diametric Capital, an estimated $169K sold.

Based on aggregated 13F filings for Q2 2020.